Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...

A groundbreaking cancer study led by Professor Tom Bird from the Cancer Research UK Scotland Institute has discovered a drug ...

A new study in the Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I ...

SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.

Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

Innovative therapies and surgical techniques have the potential to transform liver cancer care. People with cirrhosis—a ...

There are a number of ways to treat liver cancer. Tomoaki Kato, MD, discusses the effectiveness of local or regional radiation for treating liver cancer.

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...

When Lauren and Joe Sewell welcomed their daughter Violette, they immediately suspected something was wrong, but doctors ...

A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a ...

Liver cancer is the sixth most frequent cancer worldwide, mainly represented by HCC, accounting for about 85-90 per cent ...